Clinical Trial Update: Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device

View source ↗

Summary

The clinical trial evaluating nocturnal hypoglycemia monitoring with the EarlySense monitoring device for Type 1 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: EarlySense Ltd. | Conditions: Type I Diabetes | Status: WITHDRAWN